| CACNA1H |
CACNA1H: Voltage-dependent T-type calcium channel subunit alpha-1H |
SCN5A |
IPI00737026 |
2.622 |
Evidence |
|
| TRPA1 |
TRPA1, ANKTM1: Transient receptor potential cation channel subfamily A member 1 |
CACNA1F |
CACNA1F: Uncharacterized protein CACNA1F |
2.622 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
NTRK1 |
NTRK1, TRK: High affinity nerve growth factor receptor precursor |
2.622 |
Evidence |
|
| HCN1 |
HCN1, BCNG1: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gate |
CACNA1D |
CACNA1D, CACH3, CACN4, CACNL1A2, CCHL1A2: Voltage-dependent L-type calcium chann |
2.622 |
Evidence |
|
| MSC |
MSC, ABF1: Musculin |
TFEC |
TFEC, Tfec, tcag7.74: TFEC isoform |
2.622 |
Evidence |
|
| TCF21 |
TCF21, POD1: Transcription factor 21 |
PHTF1 |
PHTF1, PHTF: Putative homeodomain transcription factor 1 |
2.622 |
Evidence |
|
| KCNQ3 |
KCNQ3: Potassium voltage-gated channel subfamily KQT member 3 |
TRPC1 |
TRPC1, TRP1: Short transient receptor potential channel 1 |
2.622 |
Evidence |
|
| BCL2L11 |
BCL2L11, BIM: Bcl-2-like protein 11 |
BOK |
BOK: Bcl-2-related ovarian killer protein |
2.622 |
Evidence |
|
| BCL2L11 |
BCL2L11, BIM: Bcl-2-like protein 11 |
BCL2L12 |
BCL2L12, BPR: Bcl-2-related proline-rich protein |
2.622 |
Evidence |
|
| BCL2L11 |
BCL2L11, BIM: Bcl-2-like protein 11 |
BCL2L14 |
BCL2L14, BCLG: Apoptosis facilitator Bcl-2-like 14 protein |
2.622 |
Evidence |
|
| BCL2L11 |
BCL2L11, BIM: Bcl-2-like protein 11 |
BBC3 |
BBC3, PUMA: Bcl-2-binding component 3 |
2.622 |
Evidence |
|
| CACNA1G |
IPI00219398 |
TRPC1 |
TRPC1, TRP1: Short transient receptor potential channel 1 |
2.622 |
Evidence |
|
| MEFV |
IPI00375378 |
NALP5 |
NLRP5, MATER, NALP5: NACHT, LRR and PYD domains-containing protein 5 |
2.622 |
Evidence |
|
| MEFV |
IPI00375378 |
CASP5 |
CASP5, ICH3: Caspase-5 precursor |
2.622 |
Evidence |
|
| PSMD14 |
PSMD14, POH1: 26S proteasome non-ATPase regulatory subunit 14 |
COPS8 |
COPS8, CSN8: COP9 signalosome complex subunit 8 |
2.622 |
Evidence |
|
| HRK |
HRK, BID3: Activator of apoptosis harakiri |
BCL2L12 |
BCL2L12, BPR: Bcl-2-related proline-rich protein |
2.622 |
Evidence |
|
| LHCGR |
LHCGR, LCGR, LGR2, LHRHR: Lutropin-choriogonadotropic hormone receptor precursor |
CALR |
CALR, CRTC: Calreticulin precursor |
2.622 |
Evidence |
|
| RAB36 |
RAB36: Ras-related protein Rab-36 |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
2.622 |
Evidence |
|
| MPDZ |
MPDZ, MUPP1: Multiple PDZ domain protein |
KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
2.622 |
Evidence |
|
| BMPR1B |
BMPR1B: Bone morphogenetic protein receptor type IB precursor |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
2.622 |
Evidence |
|
| RAPH1 |
IPI00656088 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
2.62 |
Evidence |
|
| IKBKE |
IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
2.62 |
Evidence |
|
| IKBKE |
IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
2.62 |
Evidence |
|
| IKBKE |
IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit |
RYR2 |
RYR2: Ryanodine receptor 2 |
2.62 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
PTPRE |
PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor |
2.62 |
Evidence |
|
- 
- 
-